The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.80
Bid: 162.80
Ask: 163.20
Change: -2.40 (-1.45%)
Spread: 0.40 (0.246%)
Open: 167.00
High: 167.00
Low: 162.80
Prev. Close: 165.20
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Oct 2018 07:00

RNS Number : 6525D
Sabre Insurance Group PLC
11 October 2018
 

11 October 2018

 

SABRE INSURANCE GROUP PLC

Trading Update

Sabre Insurance Group plc (the "Group", or "Sabre"), one of the UK's leading private motor insurance underwriters, today provides a trading update for the nine months ending 30 September 2018.

Summary

· The Group continues its strategy of focusing on underwriting profitability over growth

· Superior underwriting performance, underpinned by strong claims experience in the period under review, supports the Group's continued expectation of delivering a FY 2018 combined ratio better than our mid-70%'s target and slightly higher than the FY 2017 combined ratio, which was 68.5%

· Strong organic capital generation supports the potential for an attractive full-year dividend with a solvency coverage ratio of 195%(1) as at the end of September, above our 140% - 160% target range

· Appropriate pricing actions taken to cover anticipated claims inflation, with GWP for the first nine months of the year remaining broadly flat year on year at £162.6m(1) (2017: £165.0m). The Group maintains its expectations for FY 2018 GWP to be in line with 2017

 

Geoff Carter, Chief Executive Officer, commented:

Throughout a period of strong competition in the UK motor insurance sector, we have continued to apply our core philosophy of focusing on underwriting profitability, with volume remaining an output rather than target.

As communicated earlier in the year, we have sought to cover anticipated claims inflation and will continue this focus throughout the rest of this year. Whilst premiums for Q3 2018 were slightly below a strong comparative period in Q3 2017, we remain confident that we will end the year with premium in-line with 2017.

Our absolute focus on profitability has yielded a strong underwriting result for the year to date and has allowed us to generate significant excess capital during the period under review. Having paid an interim dividend of 7.2 pence per share, the solvency capital ratio as at 30 September 2018 is at 195%, well above our target operating range of 140%-160%. This provides the Board the option to return surplus capital to shareholders following the full-year results, should the capital position improve further throughout the remainder of 2018. 

(1) Numerical information not subject to audit

 

 

Media enquiries

Tulchan Communications LLP

James Macey White, Roger Tejwani & David Ison

020 7353 4200

sabre@tulchangroup.com

 

Investor enquiries

Sabre Insurance Group plc

Adam Westwood

adam.westwood@sabre.co.uk

07776 649 119

 

LEI code: 2138006RXRQ8P8VKGV98

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFUFISFASELS
Date   Source Headline
8th Apr 20228:42 amRNSDirector/PDMR Shareholding
1st Apr 20227:13 amRNSDividend Declaration
1st Apr 20227:00 amRNSBoard Appointment
22nd Mar 20227:00 amRNSFinal Results
14th Mar 20221:22 pmRNSDirector Declaration
11th Mar 20221:50 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSNotice of Results
21st Feb 202212:31 pmRNSHolding(s) in Company
11th Feb 202211:34 amRNSDirector/PDMR Shareholding
28th Jan 20227:00 amRNSNew Contract with Freeway Insurance Services Ltd
11th Jan 20222:27 pmRNSDirector/PDMR Shareholding
13th Dec 20211:37 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSAppointment of new additional broker
29th Nov 20217:00 amRNSDirectorate Change
11th Nov 20211:20 pmRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSNew Contract as Exclusive Underwriter to MCE
5th Nov 202111:58 amRNSDirector/PDMR Shareholding
14th Oct 20212:27 pmRNSDirector/PDMR Shareholding
14th Oct 202111:41 amRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSQ3 Trading Update
12th Oct 202112:06 pmRNSDirector/PDMR Shareholding
12th Oct 202112:02 pmRNSDirector Declaration
7th Oct 20217:00 amRNSNotice of Trading Update
17th Sep 20212:34 pmRNSDirector/PDMR Shareholding
17th Sep 20212:33 pmRNSDirector/PDMR Shareholding
13th Sep 202111:55 amRNSDirector/PDMR Shareholding
11th Aug 20219:51 amRNSDirector/PDMR Shareholding
30th Jul 202110:15 amRNSDirector/PDMR Shareholding
28th Jul 20213:14 pmRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-year Report
13th Jul 202111:24 amRNSDirector/PDMR Shareholding
13th Jul 20217:00 amRNSNotice of Results
6th Jul 202111:00 amRNSHolding(s) in Company
2nd Jul 202112:50 pmRNSDirector/PDMR Shareholding
29th Jun 202111:39 amRNSHolding(s) in Company
22nd Jun 20213:46 pmRNSHolding(s) in Company
11th Jun 202110:53 amRNSDirector/PDMR Shareholding
21st May 20212:28 pmRNSDirector/PDMR Shareholding
21st May 20212:05 pmRNSDirector/PDMR Shareholding
21st May 202110:34 amRNSDirector/PDMR Shareholding
19th May 202112:49 pmRNSHolding(s) in Company
14th May 202111:46 amRNSResults of Annual General Meeting
14th May 20217:00 amRNSTrading Statement
11th May 20211:20 pmRNSDirector/PDMR Shareholding
22nd Apr 202110:00 amRNSDirector/PDMR Shareholding Replacement
22nd Apr 20219:51 amRNSDirector/PDMR Shareholding
14th Apr 20219:01 amRNSDirector/PDMR Shareholding
13th Apr 202111:12 amRNSDirector/PDMR Shareholding
12th Apr 20214:41 pmRNSNotice of AGM
7th Apr 20212:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.